Related Experiment Video
Updated: Apr 26, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Genomic and phenotypic characterization of a multidrug-resistant Streptococcus pneumoniae 19 F ST320 isolate from a
Tiara Putri1,2, Budi Setiadi Daryono3, Endah Retnaningrum4
1The Doctoral Program, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Abstract:
Multidrug-resistant Streptococcus pneumoniae remains a major concern in Southeast Asia, yet genomic data from Indonesia are limited. Among 19 pediatric patients with suspected COVID-19 in Yogyakarta, we identified a single pneumococcal isolate, GD-BC-10, from a SARS-CoV-2-positive child. The isolate was serotyped as 19 F and was assigned to sequence type (ST) 320, which is a member of the globally disseminated clonal complex (CC) 320/271. This 19 F strain exhibits resistance to multiple drug classes, including β-lactams, macrolides, tetracyclines, lincosamides, and folate-pathway inhibitors. Whole genome sequencing revealed resistance determinants characteristic of ST320 isolates within the CC320/271 lineage, defined by the 13-11-16 allelic combination across pbp1a, pbp2b, and pbp2x, together with erm(B), mef(A), tet(M), and folA/folP determinants. Virulence profiling identified a wide array of adhesion and immune-evasion factors including both PI-1 and PI-2 pilus islets, consistent with high-fitness of pediatric lineages. Although derived from a single carrier, the genomic and phenotypic features of this isolate reflect the persistence of high-risk 19 F clones in Indonesia. These findings emphasize the need for strengthened genomic surveillance and targeted genotypic assays to support pneumococcal monitoring in pediatric clinical settings.
Insights
Multidrug-resistant Streptococcus pneumoniae, a significant threat in Southeast Asia, was identified in an Indonesian child. This 19F strain (ST320) shows extensive drug resistance, highlighting the need for genomic surveillance.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Multidrug-resistant Streptococcus pneumoniae (MDR-SP) poses a significant public health challenge, particularly in Southeast Asia.
- Genomic data on MDR-SP in Indonesia are scarce, limiting effective monitoring and control strategies.
Purpose of the Study:
- To characterize the genomic and phenotypic features of a multidrug-resistant Streptococcus pneumoniae isolate from Indonesia.
- To assess the potential public health implications of this isolate within the context of pediatric infections.
Main Methods:
- Whole genome sequencing (WGS) of the pneumococcal isolate GD-BC-10.
- Serotyping and sequence typing (ST) analysis.
- Antimicrobial resistance profiling and virulence factor analysis.
Main Results:
- A 19F Streptococcus pneumoniae isolate, designated GD-BC-10, was identified in a SARS-CoV-2-positive child in Yogyakarta, Indonesia.
- The isolate belonged to sequence type 320 (ST320), part of the globally disseminated clonal complex (CC) 320/271, and exhibited resistance to multiple drug classes (β-lactams, macrolides, tetracyclines, lincosamides, folate-pathway inhibitors).
- Genomic analysis revealed specific resistance determinants (erm(B), mef(A), tet(M), folA/folP) and virulence factors (PI-1, PI-2 pilus islets) consistent with high fitness.
Conclusions:
- The characterized 19F ST320 strain reflects the persistence of high-risk pneumococcal clones in Indonesia.
- Findings underscore the critical need for enhanced genomic surveillance and targeted genotypic assays for pneumococcal monitoring in pediatric populations.
Related Concept Videos
Atypical Pneumonia
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Modern Molecular Taxonomy

